famotidine has been researched along with Gastric Diseases in 5 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobata, Y | 1 |
| Yajima, H | 1 |
| Yamao, J | 1 |
| Tanaka, Y | 1 |
| Fukui, H | 1 |
| Takakura, Y | 1 |
| Kotani, T | 1 |
| Fujimura, T | 1 |
| Amagase, K | 1 |
| Okabe, S | 1 |
| Takeuchi, K | 1 |
| Kitano, M | 1 |
| Wada, K | 1 |
| Kamisaki, Y | 1 |
| Nakamoto, K | 1 |
| Kishimoto, Y | 1 |
| Kawasaki, H | 1 |
| Itoh, T | 1 |
| Miehsler, W | 1 |
| Püspök, A | 1 |
| Oberhuber, T | 1 |
| Vogelsang, H | 1 |
| Aabakken, L | 1 |
| Bjørnbeth, BA | 1 |
| Weberg, R | 1 |
| Viksmoen, L | 1 |
| Larsen, S | 1 |
| Osnes, M | 1 |
1 trial available for famotidine and Gastric Diseases
| Article | Year |
|---|---|
NSAID-associated gastroduodenal damage: does famotidine protection extend into the mid- and distal duodenum?
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Chromium Radioisotopes; Double-Blind Method; Duodena | 1990 |
4 other studies available for famotidine and Gastric Diseases
| Article | Year |
|---|---|
Risk factors for the development of gastric mucosal lesions in rheumatoid arthritis patients receiving long-term nonsteroidal anti-inflammatory drug therapy and the efficacy of famotidine obtained from the FORCE study.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis, Rheumatoid; Famo | 2009 |
A novel gastric lesion model induced in rats by partial gastric vascular ligation.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Disease Models, Animal; Dose-Response Relationship | 2005 |
Effects of cimetidine on acute gastric mucosal injury induced by ischemia-reperfusion in rats.
Topics: Animals; Anti-Ulcer Agents; Cimetidine; Erythrocyte Membrane; Famotidine; Gastric Mucosa; Histamine | 1997 |
Impact of different therapeutic regimens on the outcome of patients with Crohn's disease of the upper gastrointestinal tract.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Crohn Disease; Data Interpretatio | 2001 |